Ítem
Solo Metadatos

Clinical comparisons of RA between different populations: are they feasible?

Mostrar el registro sencillo de la publicación
dc.creatorCadena, Jspa
dc.creatorAnaya, Juan-Manuelspa
dc.date.accessioned2020-08-28T15:48:10Z
dc.date.available2020-08-28T15:48:10Z
dc.date.created2003-10-28spa
dc.description.abstractRheumatoid arthritis (RA) is the most common chronic inflammatory disease affecting about 1% of the white population, particularly female patients, and has considerable physical, psychological, and social repercussions.1 In a paper published previously in the Annals, Dadoniene et al described and compared two cohorts of patients with RA from Vilnius (Lithuania) and Oslo (Norway).2 There were no significant differences in sex, age, extra-articular manifestations, education, or family history of RA between the groups. None the less, there were important differences in disease activity, disability, pain, emotional, mental and general health, with patients in the Vilnius group having the worst scores. The number of patients who had never used a disease modifying antirheumatic drug (DMARD) was similar in both groups. Vilnius patients had more commonly used azathioprine, sulfasalazine, and antimalarial drugs, whereas Oslo patients had used methotrexate, gold salts, cyclosporin, and D-penicillamine. Surgery was more common in the Oslo patients. That study was developed to compare the evolution and outcomes of two different populations with RA and was the first to include health related quality of life. The authors attributed the differences between these groups to differences in economic status, medical care, drugs used and, to a lesser extent, genetic differences.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttp://dx.doi.org/10.1136/ard.62.11.1124
dc.identifier.issnISSN: 0003-4967
dc.identifier.issnEISSN: 1468-2060
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/28426
dc.language.isoengspa
dc.publisherAnnals of the Rheumatic Diseasesspa
dc.publisherBMJ Publishingspa
dc.relation.citationEndPage1125
dc.relation.citationIssueNo. 11
dc.relation.citationStartPage1124
dc.relation.citationTitleAnnals of the Rheumatic Diseases
dc.relation.citationVolumeVol. 62
dc.relation.ispartofAnnals of the Rheumatic Diseases, ISSN: 0003-4967;EISSN: 1468-2060, Vol. 62, No. 11 (Nov. 2003); pp. 1124-1125spa
dc.relation.urihttps://ard.bmj.com/content/annrheumdis/62/11/1124.1.full.pdfspa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.sourceAnnals of the Rheumatic Diseasesspa
dc.source.instnameinstname:Universidad del Rosario
dc.source.reponamereponame:Repositorio Institucional EdocUR
dc.subject.keywordRheumatoid arthritis (RA)spa
dc.subject.keywordChronic inflammatory diseasespa
dc.subject.keywordHLAspa
dc.titleClinical comparisons of RA between different populations: are they feasible?spa
dc.title.TranslatedTitleComparaciones clínicas de AR entre diferentes poblaciones: ¿son factibles?spa
dc.typearticleeng
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.type.spaArtículospa
Archivos
Colecciones
Artículos